Leading the way in a new clinical trial
Exact Sciences has identified ECHO as the highest enroller nationally for the cancer cohort for their Ascend 2 clinical trial. This primary endpoint of this trial is hopefully identifying biomarkers for early detection of cancer. ECHO is recruiting healthy individuals with no […]
Read more »